Menu
Surgical Intervention
Major Operative Suite
Major Operative Suite Invasive Expected Stay: 2 Days

Trabeculectomy

Protocol / Details

Trabeculectomy is a major glaucoma filtration surgery. The procedure involves creating a partial-thickness scleral flap, performing a peripheral iridectomy, and excising a segment of the trabecular meshwork to facilitate aqueous humor drainage from the anterior chamber into the subconjunctival space, creating a filtering bleb to lower intraocular pressure.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Patient must adhere to strict fasting for 8 hours prior to surgery. Administer topical antibiotic prophylaxis and pupil-dilating drops as indicated. Perform comprehensive cardiovascular assessment, verify coagulation profile, and confirm signed informed consent for general or retrobulbar anesthesia.

Post-operative admission for 24-48 hours. Monitor for anterior chamber depth, intraocular pressure, and bleb formation. Administer topical steroids and antibiotics. Instruct patient on eye protection using a shield, avoidance of heavy lifting, and strict follow-up schedule for titration of care.

Comprehensive Clinical Guide: Trabeculectomy

1. Introduction and Overview

A trabeculectomy is a gold-standard surgical procedure utilized primarily in the management of advanced or uncontrolled glaucoma. Often referred to as "filtering surgery," its primary objective is to lower intraocular pressure (IOP) to a level that prevents further optic nerve damage and subsequent vision loss.

Glaucoma, characterized by progressive optic neuropathy, is frequently associated with elevated IOP. When medical management (topical eye drops) and laser therapies (such as Selective Laser Trabeculoplasty) fail to achieve the target pressure, surgical intervention becomes necessary. The trabeculectomy creates a new pathway for aqueous humor to drain from the anterior chamber into the subconjunctival space, forming a "bleb"—a small, fluid-filled reservoir under the conjunctiva—from which the fluid is absorbed into the systemic circulation.

2. Technical Specifications and Mechanism of Action

The physiological mechanism of a trabeculectomy relies on the creation of a guarded fistula. By surgically removing a small portion of the trabecular meshwork and creating a scleral flap, the surgeon provides an alternative route for aqueous humor outflow, bypassing the dysfunctional natural drainage angle.

The Anatomy of the Drainage Pathway

  1. The Fistula: A full-thickness opening created in the sclera.
  2. The Scleral Flap: A partial-thickness flap of sclera that covers the fistula, providing resistance to outflow to prevent hypotony (dangerously low eye pressure).
  3. The Bleb: The subconjunctival space where the aqueous humor accumulates before being absorbed by episcleral vessels.

Adjunctive Therapies

To prevent post-operative scarring (fibrosis), which is the most common cause of surgical failure, surgeons routinely use anti-metabolites.
* Mitomycin C (MMC): An alkylating agent that inhibits fibroblast proliferation.
* 5-Fluorouracil (5-FU): An antimetabolite often used during or after surgery to modulate wound healing.

3. Clinical Indications and Usage

Trabeculectomy is indicated for patients where medical and laser therapies have been exhausted or are deemed insufficient to stabilize the visual field.

Indication Clinical Context
Primary Open-Angle Glaucoma Failure to reach target IOP despite maximal tolerated medical therapy.
Angle-Closure Glaucoma Chronic cases where synechiae prevent aqueous outflow.
Secondary Glaucomas Certain types of uveitic or neovascular glaucoma (with caution).
Normal-Tension Glaucoma When further lowering of IOP is required to prevent progression.
Intolerance to Medications Severe ocular surface disease preventing the use of chronic drops.

4. Pre-operative Preparation

Preparation is critical for surgical success and minimizing infection risk.
* Ocular Surface Optimization: Treating blepharitis or dry eye syndrome with lid hygiene and artificial tears.
* Discontinuation of Blood Thinners: Coordination with primary care physicians to manage anticoagulants (e.g., Warfarin, Clopidogrel) if the risk/benefit ratio permits.
* Infection Prophylaxis: Initiation of topical antibiotics (e.g., fluoroquinolones) 2–3 days prior to the procedure.
* Baseline Assessment: Detailed visual field testing, optical coherence tomography (OCT) of the optic nerve, and formal IOP measurements.

5. The Procedure: Surgical Steps

The procedure is typically performed under local anesthesia with sedation.

  1. Conjunctival Incision: A peritomy is performed (usually superiorly).
  2. Scleral Flap Creation: A partial-thickness scleral flap is dissected.
  3. Application of Antimetabolites: MMC or 5-FU is applied beneath the conjunctiva for a specific duration to reduce scarring risk.
  4. Sclerostomy: A small piece of the trabecular meshwork is excised (trabeculectomy) using a punch or blade.
  5. Peripheral Iridectomy: A small portion of the iris is removed to prevent the iris from plugging the internal opening.
  6. Flap Suturing: The scleral flap is secured with sutures. The tension of these sutures is critical; they must be tight enough to prevent immediate post-op hypotony but loose enough to allow aqueous outflow.
  7. Conjunctival Closure: The conjunctiva is sutured to ensure a watertight seal.

6. Post-operative Recovery Protocol

Recovery is a dynamic process requiring frequent monitoring.

  • Immediate Post-op (Days 1–7): Frequent assessment of the bleb morphology and IOP. Anti-inflammatory steroids (topical) are used aggressively to control inflammation and prevent fibrosis.
  • The "Bleb Massage": In some cases, the surgeon may perform digital massage to encourage flow if the IOP remains higher than desired.
  • Suture Management: If laser-suture lysis is required (to open the flap further), this is performed in the clinic to increase aqueous outflow.
  • Long-term Monitoring: Patients remain on a tapering regimen of steroids for several weeks. Long-term follow-up is mandatory to monitor for "late-onset bleb leaks" or infection (blebitis).

7. Potential Complications

While highly effective, trabeculectomy carries significant risks.

Immediate Complications

  • Hypotony: IOP that is too low, potentially causing choroidal effusions or maculopathy.
  • Hyphema: Bleeding into the anterior chamber.
  • Shallow Anterior Chamber: Often a sign of over-filtration.

Late-term Complications

  • Bleb Failure: Fibrosis leads to closure of the drainage pathway and return of high IOP.
  • Endophthalmitis: A rare but devastating intraocular infection. The presence of a thin-walled, cystic bleb increases this risk throughout the patient's life.
  • Cataract Progression: Surgery can accelerate the development of lens opacities.

8. Alternative Treatments

Due to the risks associated with trabeculectomy, newer interventions are often considered:
* Ex-PRESS Shunt: A metallic device placed under the scleral flap to standardize flow.
* MIGS (Minimally Invasive Glaucoma Surgery): Procedures like iStent, Xen Gel Stent, or Hydrus Microstent, which generally have a better safety profile but lower IOP-lowering efficacy than trabeculectomy.
* Tube Shunt Surgery (e.g., Baerveldt/Ahmed implants): Often reserved for complex, refractory glaucoma cases where trabeculectomy is likely to fail.

9. Frequently Asked Questions (FAQ)

Q1: Is trabeculectomy a cure for glaucoma?
A: No. It is a management procedure that lowers pressure to slow or stop further damage. It cannot reverse existing vision loss.

Q2: How long does the surgery take?
A: Typically 45 to 90 minutes, depending on the complexity of the eye.

Q3: Will I still need eye drops after the surgery?
A: Many patients can reduce or eliminate the need for drops, but some may still require medication to maintain their target pressure.

Q4: What is a "bleb" and is it dangerous?
A: A bleb is a small blister under the eyelid. It is necessary for the surgery to work. However, it can become infected, so patients must report any redness or discharge immediately.

Q5: How long is the recovery period?
A: Visual recovery usually takes 4–6 weeks. Patients must avoid strenuous activity and swimming during this time.

Q6: What is the success rate of a trabeculectomy?
A: Success rates are generally high (70–90% at one year), but success depends heavily on the patient's healing response and the use of anti-scarring agents.

Q7: Can I fly in an airplane after surgery?
A: Usually, yes, but you must consult your surgeon, especially if a gas bubble was used during the procedure.

Q8: Is the surgery painful?
A: The procedure itself is painless due to anesthesia. Post-operatively, there may be mild discomfort or a "foreign body" sensation for a few days.

Q9: What happens if the bleb fails?
A: If the bleb scars over, the IOP will rise. The surgeon may try to "needling" the bleb in the office or recommend a revision surgery or tube shunt.

Q10: Are there any activities I can never do again?
A: Most patients return to normal life. However, contact sports or activities with a high risk of eye trauma should be discussed with your ophthalmologist due to the delicate nature of the bleb.

10. Clinical Summary for Patients and Practitioners

The trabeculectomy remains a cornerstone of glaucoma surgery. While the advent of MIGS has provided safer alternatives, the trabeculectomy’s ability to achieve very low target pressures makes it indispensable for severe, advanced disease. Success hinges on a balance between surgical precision, meticulous post-operative management of inflammation, and patient compliance with follow-up protocols. Physicians must remain vigilant for late-onset complications, particularly endophthalmitis, educating patients to recognize the signs of ocular infection throughout their lifetime.

Share this procedure: